Cwm LLC Acquires 10,580 Shares of Danaher Corporation $DHR

Cwm LLC boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 28.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 47,521 shares of the conglomerate’s stock after purchasing an additional 10,580 shares during the quarter. Cwm LLC’s holdings in Danaher were worth $9,422,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. WFA of San Diego LLC purchased a new position in shares of Danaher in the second quarter worth $26,000. Howard Hughes Medical Institute bought a new stake in Danaher in the 2nd quarter valued at $27,000. Red Tortoise LLC lifted its stake in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Heartwood Wealth Advisors LLC bought a new position in shares of Danaher during the 3rd quarter valued at about $37,000. Finally, Ramirez Asset Management Inc. purchased a new position in shares of Danaher during the second quarter valued at about $40,000. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other news, Director Teri List sold 3,298 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. This represents a 66.34% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 30,248 shares of company stock worth $6,609,663. 11.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Jefferies Financial Group boosted their target price on Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Deutsche Bank Aktiengesellschaft upped their price objective on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Finally, Bank of America dropped their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $248.25.

Danaher Stock Performance

Shares of NYSE:DHR opened at $230.74 on Tuesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a market capitalization of $162.98 billion, a price-to-earnings ratio of 47.58, a PEG ratio of 4.45 and a beta of 0.89. The firm’s 50-day moving average is $223.11 and its 200 day moving average is $208.40.

Danaher (NYSE:DHR) last announced its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the business earned $1.71 earnings per share. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. Research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.